ReP USP - Resultado da busca

Artigo de periodico
The role of dendritic cells in COVID-19 infection (2023)
Wang, Xuying; Miller, Heather; Byazrova, Maria G. ; Candotti, Fabio ; Benlagha, Kamel ; Lei, Jiahui; Filatov, Alexander ; Liu, Chaohong ; Câmara, Niels Olsen Saraiva
Source: Emerging Microbes & Infections. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, CITOCINAS, COVID-19, INFECÇÕES POR VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Xuying et al. The role of dendritic cells in COVID-19 infection. Emerging Microbes & Infections, v. 12, n. 1, p. 1-9, 2023Tradução . . Disponível em: https://doi.org/10.1080/22221751.2023.2195019. Acesso em: 04 nov. 2024.
APA
Wang, X., Miller, H., Byazrova, M. G., Candotti, F., Benlagha, K., Lei, J., et al. (2023). The role of dendritic cells in COVID-19 infection. Emerging Microbes & Infections, 12( 1), 1-9. doi:10.1080/22221751.2023.2195019
NLM
Wang X, Miller H, Byazrova MG, Candotti F, Benlagha K, Lei J, Filatov A, Liu C, Câmara NOS. The role of dendritic cells in COVID-19 infection [Internet]. Emerging Microbes & Infections. 2023 ; 12( 1): 1-9.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1080/22221751.2023.2195019
Vancouver
Wang X, Miller H, Byazrova MG, Candotti F, Benlagha K, Lei J, Filatov A, Liu C, Câmara NOS. The role of dendritic cells in COVID-19 infection [Internet]. Emerging Microbes & Infections. 2023 ; 12( 1): 1-9.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1080/22221751.2023.2195019
Artigo de periodico
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity (2023)
Baiocchi, Gabriela Crispim ; Vojdani, Aristo ; Rosenberg, Avi Z. ; Vojdani, Elroy ; Halpert, Gilad ; Yuri Ostrinski ; Israel Zyskind ; Filgueiras, Igor Salerno ; Schimke, Lena Friederike ; Marques, Alexandre Henrique Carvalho ; Giil, Lasse M. ; Lavi, Yael Bublil ; Silverberg, Jonathan I. ; Zimmerman, Jason; Hill, Dana Ashley ; Thornton, Amanda ; Kim, Myungjin; Vito, Roberta De ; Fonseca, Dennyson Leandro Mathias da ; Plaça, Desireé Rodrigues ; Freire, Paula Paccielli ; Carmen Scheibenbogen ; Heidecke, Harald; Lattin, Miriam T.; Ochs, Hans D. ; Gabriela Riemekasten ; Howard Amital ; Yehuda Shoenfeld ; Câmara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Marques, Otavio Cabral
Source: Journal of Medical Virology. Unidades: ICB, FCF
Subjects: IMUNOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, INFECÇÕES POR VÍRUS DE RNA, DOENÇAS AUTOIMUNES, AUTOANTICORPOS, IMUNOPROTEÍNAS, CITOCINAS, QUIMIOCINAS, IMUNOGLOBULINAS, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAIOCCHI, Gabriela Crispim et al. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity. Journal of Medical Virology, v. 95, n. 1, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.1002/jmv.28538. Acesso em: 04 nov. 2024.
APA
Baiocchi, G. C., Vojdani, A., Rosenberg, A. Z., Vojdani, E., Halpert, G., Yuri Ostrinski,, et al. (2023). Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity. Journal of Medical Virology, 95( 1), 1-13. doi:10.1002/jmv.28538
NLM
Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Yuri Ostrinski, Israel Zyskind, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, Vito RD, Fonseca DLM da, Plaça DR, Freire PP, Carmen Scheibenbogen, Heidecke H, Lattin MT, Ochs HD, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, Câmara NOS, Calich VLG, Marques OC. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity [Internet]. Journal of Medical Virology. 2023 ; 95( 1): 1-13.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/jmv.28538
Vancouver
Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Yuri Ostrinski, Israel Zyskind, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, Vito RD, Fonseca DLM da, Plaça DR, Freire PP, Carmen Scheibenbogen, Heidecke H, Lattin MT, Ochs HD, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, Câmara NOS, Calich VLG, Marques OC. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity [Internet]. Journal of Medical Virology. 2023 ; 95( 1): 1-13.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/jmv.28538
Artigo de periodico
Pyronaridine protects against SARS-CoV-2 infection in mouse (2022)
Puhl, Ana C. ; Gomes, Giovanni Freitas; Damasceno, Samara; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto ; Monakhova, Natalia; Riabova, Olga; Lane, Thomas R.; Makarov, Vadim; Veras, Flávio Protásio ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Oliva, Glaucius ; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Ekins, Sean
Source: ACS Infectious Diseases. Unidades: FMRP, IFSC
Subjects: COVID-19, IMUNOLOGIA, AGENTES ANTIMICROBIANOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, v. 8, n. 6, p. 1147-1160, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.2c00091. Acesso em: 04 nov. 2024.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., et al. (2022). Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, 8( 6), 1147-1160. doi:10.1021/acsinfecdis.2c00091
NLM
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091
Vancouver
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 04 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Transglutaminase type 2 is involved in the hematopoietic stem cells homeostasis (2020)
Oliverio, S.; Beltran, Jackeline Soares de Oliveira; Occhigrossi, L.; Bordoni, V.; Agrati, C.; D’Eletto, M.; Rossin, F.; Borelli, Primavera ; Amarante-Mendes, João Gustavo Pessini ; Demidov, O.; Barlev, N. A.; Piacentini, M.
Source: Biochemistry. Unidades: FCF, ICB
Subjects: IMUNOLOGIA, CÉLULAS-TRONCO, HEMATOPOESE, HOMEOSTASE, PROTEÍNAS, CÉLULAS MORTAS, CAMUNDONGOS, MEDULA ÓSSEA DE ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVERIO, S. et al. Transglutaminase type 2 is involved in the hematopoietic stem cells homeostasis. Biochemistry, v. 85, n. 10, p. 1159-1168, 2020Tradução . . Disponível em: https://doi.org/10.1134/S0006297920100041. Acesso em: 04 nov. 2024.
APA
Oliverio, S., Beltran, J. S. de O., Occhigrossi, L., Bordoni, V., Agrati, C., D’Eletto, M., et al. (2020). Transglutaminase type 2 is involved in the hematopoietic stem cells homeostasis. Biochemistry, 85( 10), 1159-1168. doi:10.1134/S0006297920100041
NLM
Oliverio S, Beltran JS de O, Occhigrossi L, Bordoni V, Agrati C, D’Eletto M, Rossin F, Borelli P, Amarante-Mendes JGP, Demidov O, Barlev NA, Piacentini M. Transglutaminase type 2 is involved in the hematopoietic stem cells homeostasis [Internet]. Biochemistry. 2020 ; 85( 10): 1159-1168.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1134/S0006297920100041
Vancouver
Oliverio S, Beltran JS de O, Occhigrossi L, Bordoni V, Agrati C, D’Eletto M, Rossin F, Borelli P, Amarante-Mendes JGP, Demidov O, Barlev NA, Piacentini M. Transglutaminase type 2 is involved in the hematopoietic stem cells homeostasis [Internet]. Biochemistry. 2020 ; 85( 10): 1159-1168.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1134/S0006297920100041
Artigo de periodico
The global response to the COVID-19 pandemic: how have immunology societies contributed ? (2020)
Osier, Faith; Ting, Jenny P. Y.; Fraser, John; Lambrecht, Bart N.; Romano, Marta; Gazzinelli, Ricardo Tostes ; Bortoluci, Karina Ramalho ; Zamboni, Dario Simões ; Akbar, Arne N.; Evans, Jennie; Brown, Doug E.; Patel, Kamala D.; Wu, Yuzhang; Perez, Ana Beatriz Alvarez; Pérez, Oliver; Kamradt, Thomas; Falk, Christine; Barda-Saad, Mira; Ariel, Amiram; Santoni, Angela; Annunziato, Francesco; Cassatella, Marco A.; Kiyono, Hiroshi; Chereshnev, Valeriy; Dieye, Alioune; Mbow, Moustapha; Mbengue, Babacar; Niang, Maguette D. S.; Suchard, Melinda
Source: Nature Reviews Immunology. Unidade: FMRP
Subjects: ANTIVIRAIS, USOS TERAPÊUTICOS, IMUNOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, PREVENÇÃO DE DOENÇAS, EPIDEMIOLOGIA, VACINAS, EDUCAÇÃO DO PACIENTE, EQUIPAMENTO DE PROTEÇÃO INDIVIDUAL, PNEUMONIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSIER, Faith et al. The global response to the COVID-19 pandemic: how have immunology societies contributed ?. Nature Reviews Immunology, v. 20, p. 594-602, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41577-020-00428-4. Acesso em: 04 nov. 2024.
APA
Osier, F., Ting, J. P. Y., Fraser, J., Lambrecht, B. N., Romano, M., Gazzinelli, R. T., et al. (2020). The global response to the COVID-19 pandemic: how have immunology societies contributed ? Nature Reviews Immunology, 20, 594-602. doi:10.1038/s41577-020-00428-4
NLM
Osier F, Ting JPY, Fraser J, Lambrecht BN, Romano M, Gazzinelli RT, Bortoluci KR, Zamboni DS, Akbar AN, Evans J, Brown DE, Patel KD, Wu Y, Perez ABA, Pérez O, Kamradt T, Falk C, Barda-Saad M, Ariel A, Santoni A, Annunziato F, Cassatella MA, Kiyono H, Chereshnev V, Dieye A, Mbow M, Mbengue B, Niang MDS, Suchard M. The global response to the COVID-19 pandemic: how have immunology societies contributed ? [Internet]. Nature Reviews Immunology. 2020 ; 20 594-602.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41577-020-00428-4
Vancouver
Osier F, Ting JPY, Fraser J, Lambrecht BN, Romano M, Gazzinelli RT, Bortoluci KR, Zamboni DS, Akbar AN, Evans J, Brown DE, Patel KD, Wu Y, Perez ABA, Pérez O, Kamradt T, Falk C, Barda-Saad M, Ariel A, Santoni A, Annunziato F, Cassatella MA, Kiyono H, Chereshnev V, Dieye A, Mbow M, Mbengue B, Niang MDS, Suchard M. The global response to the COVID-19 pandemic: how have immunology societies contributed ? [Internet]. Nature Reviews Immunology. 2020 ; 20 594-602.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41577-020-00428-4
Artigo de periodico
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation (2017)
Morena, Maria Teresa de la ; Leonard, David; Torgerson, Troy R.; Marques, Otavio Cabral; Slatter, Mary Anne; Aghamohammadi, Asghar ; Chandra, Sharat; Favela, Luis Murguia ; Bonilla, Francisco A. ; Kanariou, Maria; Damrongwatanasuk, Rongras; Kuo, Caroline Y.; Dvorak, Christopher C. ; Meyts, Isabelle; Chen, Karin ; Kobrynski, Lisa ; Kapoor, Neena; Richter, Darko ; DiGiovanni, Daniela; Dhalla, Fatima ; Farmaki, Evangelia ; Speckmann, Carsten ; Español, Teresa; Shcherbina, Anna YU ; Hanson, Imelda Celine Guerra; Litzman, Jiri ; Routes, John M. ; Wong, Melanie; Fuleihan, Ramsay ; Seneviratne, Suranjith L. ; Small, Trudy N.; Janda, Ales ; Bezrodnik, Liliana; Seger, Reinhard; Raccio, Andrea Gomez; Edgar, John David M. ; Chou, Janet ; Abbott, Jordan Keith ; Montfrans, Joris van ; Granado, Luis Ignacio González ; Bunin, Nancy; Kutukculer, Necil ; Gray, Paul ; Seminario, Gisela; Pasic, Srdjan ; Aquino, Victor; Wysocki, Christian ; Abolhassani, Hassan ; Dorsey, Morna ; Rundles, Charlotte Cunningham ; Knutsen, Alan Paul ; Sleasman, John William ; Carvalho, Beatriz Tavares Costa ; Condino-Neto, Antonio ; Grunebaum, Eyal ; Chapel, Helen ; Ochs, Hans Dieter; Filipovich, Alexandra Hult; Cowan, Mort; Gennery, Andrew ; Cant, Andrew James ; Notarangelo, Luigi D. ; Roifman, Chaim M.
Source: Journal of Allergy and Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS-TRONCO, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, HEMATOPOESE, CÉLULAS SANGUÍNEAS, IMUNOLOGIA CELULAR, DOENÇAS AUTOIMUNES, DOENÇAS IMUNOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENA, Maria Teresa de la et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, v. 139, n. 4, p. 1282-1292, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2016.07.039. Acesso em: 04 nov. 2024.
APA
Morena, M. T. de la, Leonard, D., Torgerson, T. R., Marques, O. C., Slatter, M. A., Aghamohammadi, A., et al. (2017). Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, 139( 4), 1282-1292. doi:10.1016/j.jaci.2016.07.039
NLM
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039
Vancouver
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration